NEI Research News

Jordan Hamm, an assistant professor of neuroscience at Georgia State University, has received a five-year, $1.93 million award from the National Eye Institute.

Researchers say findings reveal potential glaucoma drugs targets.

Rogue clinics offer stem cell-based therapies that haven’t been tested for safety and efficacy. When communicating to the public about stem cell-based therapies, it is important to put any treatment claims in context.

A UCLA-led group found that the eye drug verteporfin stops replication of SARS-CoV-2, the virus that causes COVID-19.

Columbia University researchers examined what goes wrong in the eyes of mice with albinism.

NEI grant will support examining impact of pain and inflammation on eye’s surface and possible link to diseases.

Using a new stem-cell based model made from skin cells, scientists found the first direct evidence that Stargardt-related ABCA4 gene mutations affect a layer of cells in the eye called the retinal pigment epithelium (RPE).

Scientists have discovered a mechanism by which an area of a protein shape-shifts to convert vitamin A into a usable form for the eye’s light-sensing photoreceptor cells.

An unprecedented study of brain plasticity and visual perception found that people who, as children, had undergone surgery removing half of their brain correctly recognized differences between pairs of words or faces more than 80% of the time.

The Anterior Segment Initiative has funded eight research projects to explore the innervation of the eye’s surface.